Comparison between the effect of Two Regimens for Hepatitis C Treatment (Qurevo and Ribavirin) and (Sofosbuvir, Daclatsvir and Ribavirin) on Patients above and below the Age of 60 Years
Journal Title: The Egyptian Journal of Hospital Medicine - Year 2018, Vol 72, Issue 10
Abstract
<strong>Background:</strong> the goal of antiviral treatment is to prevent complications of the disease, mainly cirrhosis and HCC. New therapy options, known as direct acting antiviral (DAA) regimens, offer the promise of increased success rates complimented by shorter treatment durations, improve side effect profiles, and simplified treatment monitoring. <strong>Aim of the Work:</strong> to compare between the effect of oral antiviral treatment especially (Quervo and Ribavirin) and (Sofosbuvir, Daclatasvir and Ribavirin) between elderly patients above 60 years and young people below this age as regard: Response to treatment, Development of complication. <strong>Patients and Methods:</strong> the study was conducted on 100 Egyptian patients they were divided into 2 groups each one received one of the two treatment regimens then each group divided into 2 subgroups, subgroup A include patients below 60 years and subgroup B include patients above 60 years. The selected patients were subjected to History taking, Complete physical examination, Pelviabdominal ultrasound, Laboratory investigations: complete blood count, bilirubin and liver enzymes before and after treatment, INR, creatinine, albumin, HBs Ag, HIV antibodies and Alpha feto proteins, HCV RNA. <strong>Results:</strong> there is no significant difference between two treatment regimens. Both regimens show cure rate about 94%, 96% achieved SVR with (sofosbuvir daclatasvir and ribavirin regimen), (quervo and ribavirin regimen) respectively. Both regimens are effective in elderly patients above 60 years as young patients below this age in both regimens, response of treatment in both regimens in elderly patients above 60 years is 96%. Gender doesn't affect treatment outcome. Anemia develop in 34% of patients receiving sofosbuvir, daclatasvir and ribavirin regimen, and in 58% of patients receiving quervo and ribavirin regimen. Females developed anemia more frequent than males in both regimens. Both regimens developed hepatobiliary complication, 12%, 18% developed hyperbilirubinemia with (sofosbuvir daclatasvir and ribavirin regimen), (quervo and ribavirin regimen) respectively. <strong>Conclusion:</strong> treatment with (sofosbuvir daclatasvir and ribavirin regimen) or (quervo and ribavirin regimen) is highly effective with little differences between them; also age and gender have no role in achieving SVR. Complications such as anemia and hyperbilirubinemia occur in treatment with both regimens and more frequent with (quervo and ribavirin regimen).
Authors and Affiliations
Eman Helal
Keywords
Related Articles
- EP ID EP584339
- DOI 10.12816/ejhm.2018.11284
- Views 124
- Downloads 0
Effect of Apocynin on Liver Toxicity Induced by Microwaves in Rats
Background: electromagnetic waves could cause oxidative stress and generate ROS that lead to free radical production and lipid peroxidation which damage liver tissue. Apocynin (APO) exerts its antioxidant effect by reduc...
Effect of Honey Supplementation on Clostridium Difficile Infection in Childhood Cancer
<strong>Background: </strong>the treatment of cancer is associated with nausea and vomiting, oral mucositis, constipation, xerostomia and diarrhea and weight loss, additionally; chemotherapeutic agents promote inflammato...
Assessment of Pelvic Parameters before and after Postero-lateral Interbody Fusion Surgery in Patient with Lumbo-sacral Instability
<strong>Background: </strong>pelvic incidence (PI) is a fundamental pelvic anatomic parameter that is specific and constant for each individual and determines pelvic orientation as well as the size of lumbar lordosis (LL...
Overview of Allopurinol Decisions in Primary Care: A Narrative Review
<span>Background: </span><span>Allopurinol is a type of drug called a xanthine oxidase inhibitor. It functions by lowering the production of uric acid in the body. It can be found in the kind of an oral tablet. Generalis...
Role of Botulinum Toxin Type A in Management of Vocal Fold Contact Granuloma Meta-Analysis Study
<span>Background: </span><span>granulomas of the vocal process of the larynx are benign lesions of the posterior glottis generally centered over the tips of the cartilaginous vocal processes. Clinically they are associat...